Author

S. Freedman

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Organism:E. coli· 1 Approach:experimental assay· 1 Organism:human· 1 Research Focus:phylogenetics / evolution· 1 Research Focus:protein folding & dynamics· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Bose· 1 shared A. Emili· 1 shared B. Bockorny· 1 shared C. R. Laing· 1 shared D. Akshinthala· 1 shared E. Rouse· 1 shared E. W. Bumunang· 1 shared G. A. M. Tarr· 1 shared

Activity by Year

2019-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Bose

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Persistent cross-species transmission systems dominate Shiga toxin-producing Escherichia coli O157:H7 epidemiology in a high incidence region: a genomic epidemiology study

G. A. M. Tarr, L. Chui, K. Stanford, E. W. Bumunang, R. Zaheer, V. Li, S. Freedman, C. R. Laing, T. A. McAllister

This study identifies persistent cross-species transmission systems between cattle and humans as a major driver of E. coli O157:H7 epidemiology in Alberta, with a shift toward more virulent stx2a-only strains.

bioRxiv · Apr 5, 2024Microbiology

Pancreatic tumor organoids for modeling in vivo drug response and discovering clinically-actionable biomarkers

l. huang, B. Bockorny, I. Paul, D. Akshinthala, O. Gandarilla, A. Bose, V. Sanchez-Gonzalez, E. Rouse, S. Lehoux, N. Pandell, J. Clohessy, J. Grossman, R. Gonzalez, S. Perea del Pino, G. Daaboul, , S. Muthuswamy

This paper demonstrates that pancreatic tumor organoids (PDOs) recapitulate PDX models' features and can identify clinically-actionable biomarkers in blood.

bioRxiv · Jan 28, 2019 · PreprintCancer Biology